Acenocoumarol: A Review of Anticoagulant Efficacy and Safety.

Abhijit Trailokya, J S Hiremath, Jps Sawhney, Y K Mishra, Vivek Kanhere, R Srinivasa, Mangesh Tiwaskar

Journal: The Journal of the Association of Physicians of India 2018;64(2):88-93

PMID: 27730796

Abstract

Anticoagulant treatment is required for the treatment and prevention of thromboembolic disorders. Vitamin K antagonists are commonly used oral anticoagulants worldwide. Acenocoumarol is mono-coumarin derivative with racemic mixture of R (+) and S (-) enantiomers. Efficacy and safety of acenocoumarol has been evaluated in atrial fibrillation, cardiac valve replacement, after myocardial infarction, treatment of deep vein thrombosis, after major surgeries and after critical illness requiring prolonged hospitalization. Acenocoumarol is effective and safe in all age groups. It offers an advantage over warfarin in terms of better stability of anti-coagulant effect. Due to its economic advantage acenocoumarol may be suitable oral anticoagulant for long term use in countries like India.

© Journal of the Association of Physicians of India 2011.

Address: Medical Services Division, Abbott Healthcare Private Limited, Mumbai, Maharashtra.; Director, Cath Lab, Ruby Hall Clinic, Pune, Maharashtra.; Sir Ganga Ram Hospital, Delhi.; Director, Department of Cardiovascular Surgery, Fortis Escorts Heart Institute & Research Centre, Delhi.; Consultant Cardiac Surgeon, Chirayu Cardiac Centre, Bhopal.; Senior Professor of Neurology and Head, Dept. of Neurology, MS Ramaiah Medical college and Hospitals, Bangalore, Karnataka.; Consultant Physician, Asian Heart Institute & Research Centre, Karuna Hospital, Mumbai, Maharashtra.

Link outs

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.